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1. Introduction 
Intravenous injection of heparin releases lipolytic 
activities against a variety of substrates including tri- 
glycerides, diglycerides, monoglycerides and phospho- 
lipids [l--5]. Triglyceride lipase (TGL) in post-heparin 
plasma has been considered to be identical with lipo- 
protein lipase (LPL), an enzyme present in adipose 
tissue, heart, mammary gland and other organs [6]. 
LPL is defined as a triglyceride lipase requiring lipo- 
proteins or apolipoproteins for full activity. When 
obtained from these tissues, LPL has been shown con- 
sistently to be inhibited by 1 M sodium chloride. Un- 
purified TGL from plasma, however, has been shown 
by various investigators to be only partially inhibited 
or even activated by sodium chloride [7-91. The 
variable inhibition by high ionic strengths has been 
attributed to the presence of more than one TGL in 
plasma [lo]. This concept has not been established 
by purification of multiple enzymes and the possibil- 
ity remains that the different activities observed may 
be in part due to differences in assay conditions or 
other factors. Recently a LPL has been isolated from 
human post-heparin plasma [ 11, 121; however, detail- 
ed studies on the effects of NaCl on these preparations 
are yet to be presented. In this publication we report 
on studies which led to a highly purified TGL from 
human post-heparin plasma. This enzyme differed 
from LPL in rat adipose tissue by failing to show 
suppressed activity in 1 M sodium chloride and thus 
is similar to that of a TGL released by heparin from liver. 
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2. Materials and methods 
2.1. Enzyme assays 
Triglyceride lipase assays were carried out as follows: 
In a total volume of 0.5 ml each vial contained i) 3.3 
nmoles of [l-‘4C]trioleate (7.3 X lo4 dpm); ii) 0.67 
pmoles of unlabeled trioleate; iii) 2.5 mg gum arabic; 
iv) 5 mg bovine albumin; v) 20 1.t1 of post-heparin 
plasma or variable amounts of enzyme solution. Final 
buffer concentrations were 0.2 M Tris-HCl (pH 8.4) 
with concentrations of sodium chloride from 0.01 to 
2 M. Incubations were done in duplicate for 30 min at 
27”. Total lipids were extracted by the method of 
Dole and Meinertz and 14C-labeled free fatty acids 
were isolated on an ion exchange resin by a modifica- 
tion [ 131 of the method of Kelley [ 141. Enzyme ac- 
tivity was calculated as nmoles [r4C]FFA/ml/hr. With 
this system enzyme activity was directly proportional 
to the amount of up to 40 ~1 of post-heparin plasma 
added. [’ 4 C]FFA release was linear with time for 1 hr 
or longer or until lo-12% of the triglyceride was 
hydrolyzed. Post-heparin plasma monoglyceride 
hydrolase (MGH) was determined by the method of 
Greten et al. [2]. 
2.2. Enzyme preparation 
Human post-heparin plasma was collected from normal 
subjects 10 min after intravenous administration of 
sodium heparin (10 units per kg body weight) [8]. 
Plasma was adjusted to d = 1.21 g/ml by the addition 
of KBr and centrifuged for 1 hr at 60,000 rpm in a 
North-Holland Publishing Company - Amsterdam 
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Fig. 1. Effect of NaCl on post-heparin plasma TGL. Representative curve demonstrating the effect of final NaCl concentrations in 
the incubate on enzyme activity is shown. 
M NaCl 
1 I I 
0 50 100 150 200 250 300 
-: 
ELUATE VOLUME (ml) 
!50 
200 
E 
150 z 
z 
3 
100 I- 
: 
n 
50 
0 
Fig. 2. Affinity chromatography of human post-heparin plasma TGL on heparin-Sepharose. A plasma sample (42 ml) of the d = 1.21 
infranatant which had been dialyzed and diluted before (Methods) was applied to the column. 200 ml of the starting buffer were 
then applied, eluting a large protein peak not shown on the figure. A gradient between 0.15 and 1.5 M NaCl with 0.005 M sodium 
barbital was then started using a total volume of 400 ml. 4 ml fractions were collected. (e-e-e) Protein measured by the Lowry 
method. (AA a- A) TGL activity. 
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Fig. 3. Affinity chromatography of partially purified TGL on a second heparin-Sepharose column. Fractions between eluate volume 
160 and 225 ml from the previous column (fig. 2) were pooled and diluted to the starting buffer concentration. Elution was perform- 
ed as described in fig. 2. Fraction marked by arrow was used for analysis by polyacrylamide gel electrophoresis (fig. 4). 
Spinco model L-2-65B ultracentrifuge using a type 65 
rotor. The upper 2 ml were discarded and the infranatant 
was dialyzed against 0.15 M sodium chloride contain- 
ing 0.005 M sodium barbital at pH 7.4 for 60 min. The 
dialyzed plasma preparation was then diluted with an 
equal volume of 0.15 M sodium chloride in 0.005 M 
sodium barbital. Sepharose 4B (Pharmacia Fine Chem- 
icals, Uppsala, Sweden) was activated by treatment 
with cyanogen bromide [ 151 and heparin was covalent- 
ly bound to the gel as described by Iverius [ 161. The 
sample was applied to a column of heparinSepharose 
(2.5 X 30 cm) and elution was carried out with a linear 
gradient of sodium chloride as described in the legend 
to fig. 2 [ 171. Rechromatography of the partially 
purified enzyme was performed in the same way on a 
second heparir-Sepharose column after diluting the 
sample to the conductivity of 0.15 M sodium chloride 
(conductivity 10 mmho) with 0.005 M sodium barbital. 
2.3. Immunological methods 
Immunoelectrophoresis was carried out in 1% aga- 
rose gel employing barbital buffer, pH 8.6, ionic 
strength 0.05. Rabbit anti-human serum was prepared 
in this laboratory for immunochemical identification 
of protein bands. Double immunodiffusion was carried 
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out by the method of Ouchterlony in the same gel [ 181. 
Polyacrylamide gel electrophoresis was performed 
in 7.5% acrylamide. The gels were prepared with and 
without urea (8 M at pH 8.9) using Tris-HCl buffer and 
protein bands were stained with Coumassie blue [ 191. 
Protein was measured by the method of Lowry et 
al. with bovine albumin as standard [20]. 
3. Results 
The effects of increasing NaCl concentrations on 
enzyme activity are shown in fig. 1. Both post-heparin 
plasma and purified TGL were maximally active be- 
tween 0.5 and 0.75 M sodium chloride but were only 
slightly less active at 1 M NaCl. Unless otherwise stated, 
enzyme assays were carried out at the 1 M sodium 
chloride concentration. We thus selected conditions 
which would exclude appreciable measurement of a 
LPL in plasma which was inactivated at high ionic 
strengths. Removal of very low density lipoproteins 
(VLDL) and low density lipoproteins (LDL) from the 
remaining plasma proteins by ultracentrifugation was 
found necessary as these lipoproteins also form com- 
plexes with heparin. Most of the plasma proteins did 
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not bind to the column and were eluted during the 
application of the sample. A much smaller protein 
peak was observed soon after the initiation of the 
sodium chloride gradient (fig. 2). The enzyme was then 
eluted as a single peak of activity with no correspond- 
ing protein peak. A third peak of protein appeared 
after the enzyme activity. Polyacrylamide gel electro- 
phoresis of the enzyme peak showed at least four bands 
(fig. 4) and by immunoelectrophoresis everal precipitin 
lines were detectable against anti-human plasma. A 
much greater purification was obtained by rechromat- 
ography of those fractions showing the highest specific 
activity on a second heparinsepharose column. This 
chromatogram is shown in fig. 3. MGH activity eluted 
with that of TGL. One fraction of this enzyme activity 
peak indicated in fig. 3 stained as a single band on poly- 
acrylamide gel electrophoresis in 8 M urea (fig. 4). This 
purified TGL was maximally active between 0.5 and 
0.75 M sodium chloride as was post-heparin plasma. 
Furthermore, addition of pre-heparin plasma was not 
found necessary for enzymatic activity. The purified 
enzyme did not react with rabbit anti-human sera on 
immunoelectrophoresis or double immuno diffusion. 
The final specific activity was 3750 nmoles [ 14C]FFA/ 
hr/mg protein, representing approx. 10,000fold 
purification from crude post-heparin plasma (table 1). 
4. Discussion 
A triglyceride lipase has been highly purified from 
human post-heparin plasma. This enzyme showed 
optimal activity in high sodium chloride concentra- 
tions and was not activated by addition of plasma. 
‘These characteristics eem to distinguish this TGL 
from the lipoprotein lipase purified from rat plasma 
[21] and bovine milk [ 171, and from that in adipose 
tissue or heart. Liver perfusates containing heparin 
[ 10,221 and liver homogenates have been shown to 
contain a TGL with the properties of the enzyme 
Fig. 4. Polyacrylamide gel electrophoresis (7.5%, 8 M urea) of 
concentrated fractions with TGL activity which were obtained 
from the first heparin-Sepharose (a) and the second heparin- 
Sepharose (b) column. A single band is seen in the separation 
gel (b). Protein staining at the interface between the upper and 
lower gel probably represents ome aggregation of the enzyme, 
perhaps occurring during the stacking process, since assay of 
gel slices (without urea) revealed enzyme activity at both sites. 
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Table 1 
Summary of the purification steps for human post-heparin plasma TGL. 
Volume Protein Total activity 
(ml) (mg) 
Specific activity (nmoles Purification 
(nmoles [ r4C]FFA/hr) [ 4C]FFA/hr/mg protein) 
Post-heparin plasma 25 3012 1160 0.39 -__ 
d = 1.21 Infranatant* 21 1386 825 0.60 1.5 
Eluate l** 60 0.74 352 475 1220 
Eluate 2*** 57 0.03 120 3750 9160 
Data represent enzyme activity in 1 M sodium chloride. Mean out of three experiments are shown. 
* Sample obtained after ultracentrifugation at density 1.21 and after dialysis. 
** Fractions collected between eluate volume 160-220 ml from the first heparin-Sepharose column were pooled. 
*** Fractions collected between 189-246 ml from the second heparin-Sepharose column were pooled. 
Yield 
(%) 
100 
71 
41 
10 
purified in this study [IO]. It is likely, therefore, that 
this TGL originates from liver. This enzyme may co- 
exist in post-heparin plasma with other TGL activity 
which is inhibited by high ionic strengths as suggested 
by LaRosa [lo]. 
Evidence has been previously presented that post- 
heparin plasma contains different lipolytic activities 
against triglycerides and micellar monoglycerides 
[ 1, 21. The purified plasma obtained in this study 
shows activity against both triglyceride emulsions 
and micellar monoglyceride solutions. TGL and MGH 
may represent two interconvertible forms of the en- 
zyme and studies with purified enzyme preparations 
will be necessary for further clarification. 
Clearly, assay conditions play an important role in 
characterizing the properties of an enzyme. Investiga- 
tors who have observed sodium chloride inhibition with 
post-heparin plasma as enzyme source have used differ- 
ent triglyceride emulsions and higher incubation tempe- 
ratures than those in this study [7,8,23]. Conditions 
required for salt inhibition are presently being investi- 
gated in our laboratory. Although pre-heparin plasma 
did not increase activity of this purified plasma enzyme, 
studies using isolated lipoproteins and their lipid and 
apoprotein components will be necessary to determine 
the need of possible cofactors. Interrelationships be- 
tween purified plasma TGL and plasma lipoproteins 
are presently under investigation in our laboratory. 
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